Nucleoporin Nup358 Drives the Differentiation of Myeloid-biased Multipotent Progenitors by Modulating HDAC3 Nuclear Translocation

Overview

Journal Sci Adv

Specialties Biology
Science

Date 2024 Jun 5

PMID 38838144

Authors

Valeria Guglielmi

Davina Lam

Maximiliano A DAngelo

Affiliations

Soon will be listed here.

Abstract

Nucleoporins, the components of nuclear pore complexes (NPCs), can play cell type- and tissue-specific functions. Yet, the physiological roles and mechanisms of action for most NPC components have not yet been established. We report that Nup358, a nucleoporin linked to several myeloid disorders, is required for the developmental progression of early myeloid progenitors. We found that Nup358 ablation in mice results in the loss of myeloid-committed progenitors and mature myeloid cells and the accumulation of myeloid-primed multipotent progenitors (MPPs) in bone marrow. Accumulated MPPs in Nup358 knockout mice are greatly restricted to megakaryocyte/erythrocyte-biased MPP2, which fail to progress into committed myeloid progenitors. Mechanistically, we found that Nup358 is required for histone deacetylase 3 (HDAC3) nuclear import and function in MPP2 cells and established that this nucleoporin regulates HDAC3 nuclear translocation in a SUMOylation-independent manner. Our study identifies a critical function for Nup358 in myeloid-primed MPP2 differentiation and uncovers an unexpected role for NPCs in the early steps of myelopoiesis.

References

Hutten S, Flotho A, Melchior F, Kehlenbach R . The Nup358-RanGAP complex is required for efficient importin alpha/beta-dependent nuclear import. Mol Biol Cell. 2008; 19(5):2300-10. PMC: 2366868. DOI: 10.1091/mbc.e07-12-1279. View

Forler D, Rabut G, Ciccarelli F, Herold A, Kocher T, Niggeweg R . RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the nuclear pore complex and functions in nuclear mRNA export. Mol Cell Biol. 2004; 24(3):1155-67. PMC: 321439. DOI: 10.1128/MCB.24.3.1155-1167.2004. View

Wilson N, Kent D, Buettner F, Shehata M, Macaulay I, Calero-Nieto F . Combined Single-Cell Functional and Gene Expression Analysis Resolves Heterogeneity within Stem Cell Populations. Cell Stem Cell. 2015; 16(6):712-24. PMC: 4460190. DOI: 10.1016/j.stem.2015.04.004. View

Kotwal A, Suran S, Amere Subbarao S . Hsp90 chaperone facilitates E2F1/2-dependent gene transcription in human breast cancer cells. Eur J Cell Biol. 2021; 100(1):151148. DOI: 10.1016/j.ejcb.2020.151148. View

Bley C, Nie S, Mobbs G, Petrovic S, Gres A, Liu X . Architecture of the cytoplasmic face of the nuclear pore. Science. 2022; 376(6598):eabm9129. PMC: 9348906. DOI: 10.1126/science.abm9129. View

Heideman M, Lancini C, Proost N, Yanover E, Jacobs H, Dannenberg J . Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis. Haematologica. 2014; 99(8):1292-303. PMC: 4116827. DOI: 10.3324/haematol.2013.092643. View

Gareau J, Lima C . The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat Rev Mol Cell Biol. 2010; 11(12):861-71. PMC: 3079294. DOI: 10.1038/nrm3011. View

Guglielmi V, Sakuma S, DAngelo M . Nuclear pore complexes in development and tissue homeostasis. Development. 2020; 147(23). PMC: 7758637. DOI: 10.1242/dev.183442. View

Scott E, Simon M, Anastasi J, Singh H . Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 1994; 265(5178):1573-7. DOI: 10.1126/science.8079170. View

10.

Nerlov C, Graf T . PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 1998; 12(15):2403-12. PMC: 317050. DOI: 10.1101/gad.12.15.2403. View

11.

Pang S, de Graaf C, Hilton D, Huntington N, Carotta S, Wu L . PU.1 Is Required for the Developmental Progression of Multipotent Progenitors to Common Lymphoid Progenitors. Front Immunol. 2018; 9:1264. PMC: 6005176. DOI: 10.3389/fimmu.2018.01264. View

12.

Kirsh O, Seeler J, Pichler A, Gast A, Muller S, Miska E . The SUMO E3 ligase RanBP2 promotes modification of the HDAC4 deacetylase. EMBO J. 2002; 21(11):2682-91. PMC: 125385. DOI: 10.1093/emboj/21.11.2682. View

13.

Pichler A, Gast A, Seeler J, Dejean A, Melchior F . The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell. 2002; 108(1):109-20. DOI: 10.1016/s0092-8674(01)00633-x. View

14.

Akashi K, He X, Chen J, Iwasaki H, Niu C, Steenhard B . Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood. 2002; 101(2):383-9. DOI: 10.1182/blood-2002-06-1780. View

15.

Bindra D, Mishra R . In Pursuit of Distinctiveness: Transmembrane Nucleoporins and Their Disease Associations. Front Oncol. 2021; 11:784319. PMC: 8712647. DOI: 10.3389/fonc.2021.784319. View

16.

Walde S, Thakar K, Hutten S, Spillner C, Nath A, Rothbauer U . The nucleoporin Nup358/RanBP2 promotes nuclear import in a cargo- and transport receptor-specific manner. Traffic. 2011; 13(2):218-33. DOI: 10.1111/j.1600-0854.2011.01302.x. View

17.

Klein F, Roux J, Cvijetic G, Rodrigues P, von Muenchow L, Lubin R . Dntt expression reveals developmental hierarchy and lineage specification of hematopoietic progenitors. Nat Immunol. 2022; 23(4):505-517. PMC: 9208307. DOI: 10.1038/s41590-022-01167-5. View

18.

Wilson A, Laurenti E, Oser G, van der Wath R, Blanco-Bose W, Jaworski M . Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008; 135(6):1118-29. DOI: 10.1016/j.cell.2008.10.048. View

19.

Kim Y, Keyser S, Schneekloth Jr J . Synthesis of 2',3',4'-trihydroxyflavone (2-D08), an inhibitor of protein sumoylation. Bioorg Med Chem Lett. 2014; 24(4):1094-7. PMC: 3970184. DOI: 10.1016/j.bmcl.2014.01.010. View

20.

Olsson A, Venkatasubramanian M, Chaudhri V, Aronow B, Salomonis N, Singh H . Single-cell analysis of mixed-lineage states leading to a binary cell fate choice. Nature. 2016; 537(7622):698-702. PMC: 5161694. DOI: 10.1038/nature19348. View